ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

ADAR2-editing activity inhibits glioblastoma growth through the modulation of the CDC14B/Skp2/p21/p27 axis

Published:2012-04-23 Issue:8 Volume:32 Page:998-1009
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Galeano F,Rossetti C,Tomaselli S,Cifaldi L,Lezzerini M,Pezzullo M,Boldrini R,Massimi L,Di Rocco C M,Locatelli F,Gallo A

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2012125.pdf

Reference59 articles.

1. Kleihues P, Burger PC, Scheithauer BW . The new WHO classification of brain tumours. Brain Pathol 1993; 3: 255–268.

2. Maher EA, Furnari FB, Bachoo RM, Rowitch DH, Louis DN, Cavenee WK et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev 2001; 15: 1311–1333.

3. Zhu Y, Parada LF . The molecular and genetic basis of neurological tumours. Nat Rev Cancer 2002; 2: 616–626.

4. Stupp R, van den Bent MJ, Hegi ME . Optimal role of temozolomide in the treatment of malignant gliomas. Curr Neurol Neurosci Rep 2005; 5: 198–206.

5. Kwon CH, Zhao D, Chen J, Alcantara S, Li Y, Burns DK et al. Pten haploinsufficiency accelerates formation of high-grade astrocytomas. Cancer Res 2008; 68: 3286–3294.

Cited by 119 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salidroside prevents gestational hypertension-induced impairment of offspring learning and memory via Wnt/Skp2 pathway;Neuroscience Letters;2024-05

2. The epitranscriptome of high-grade gliomas: a promising therapeutic target with implications from the tumor microenvironment to endogenous retroviruses;Journal of Translational Medicine;2023-12-09

3. RNA Editing in Cancer Progression;Cancers;2023-11-03

4. RNA modification: mechanisms and therapeutic targets;Molecular Biomedicine;2023-08-24

5. Advances in targeting RNA modifications for anticancer therapy;Trends in Cancer;2023-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3